Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | P2RX4 | Q99571 | 6/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7000034 | 0.81 | SMN1; SMN2 (0.59) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL367474 | 0.80 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL338 | 0.80 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL23705539 | 0.80 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL29367804 | 0.80 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL5555646 | 0.77 | SMN1; SMN2 (0.67) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| Carbimide SCHEMBL10800076 | 0.76 | SMN1; SMN2 (0.90) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| 1,2-Dichloroethane SCHEMBL28697158 | 0.76 | SMN1; SMN2 (0.90) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL30563642 | 0.76 | SMN1; SMN2 (0.78) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 | |
| SCHEMBL4742545 | 0.76 | SMN1; SMN2 (0.78) | SMN1; SMN2LMNAMAPK1P2RX4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089362-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG GROUP, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-08-19 | — | — | EP | disclosed |
| WO-2008046463-A1 | METAL CHELATES HAVING A PERFLUORINATED PEG GROUP, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-04-24 | — | — | WO | disclosed |
| EP-1904462-A2 | COMPLEXES CONTAINING PERFLUOROALKYL, METHOD FOR THE PRODUCTION AND USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-02 | — | — | EP | disclosed |
| EP-1307237-B9 | COMPLEXES CONTAINING PERFLUOROALKYL WITH POLAR RADICALS, METHOD FOR THE PRODUCTION AND USE THEREOF | BAYER SCHERING PHARMA AG (DE) | 2008-01-09 | — | — | EP | disclosed |
| EP-1088558-B1 | Galenic formulations comprising paramagnetic and diamagnetic compounds | BAYER SCHERING PHARMA AG (DE) | 2007-06-27 | — | — | EP | disclosed |
| EP-1307237-B1 | COMPLEXES CONTAINING PERFLUOROALKYL WITH POLAR RADICALS, METHOD FOR THE PRODUCTION AND USE THEREOF | BAYER SCHERING PHARMA AG (DE) | 2007-04-11 | — | — | EP | disclosed |
| WO-2007009637-A2 | COMPLEXES CONTAINING PERFLUOROALKYL, THEIR USE AS CONTRAST MEDIA FOR NMR, X-RAY AND RADIO DIAGNOSIS AND RADIOTHERAPY | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-01-25 | — | — | WO | disclosed |
| EP-1210335-B1 | AMINOCARBONYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR PRODUCING SAME AND THE USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-09-14 | — | — | EP | disclosed |
| EP-1237877-B1 | CARBOXAMIDE-SUBSTITUTED BENZIMIDAZOL DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-07-27 | — | — | EP | disclosed |
| EP-1307446-B1 | PERFLUOROALKYL-CONTAINING COMPLEXES COMPRISING SUGAR RESIDUES, METHOD FOR PRODUCING THE SAME AND USE THEREOF | SCHERING AG (DE) | 2005-04-20 | — | — | EP | disclosed |
| EP-0697023-B1 | 3-(AMINOACYL-AMINO)-SACCHARIDES AND METHOD FOR PREPARING THEM | ZUCKERINDUSTRIE VEREIN (DE) | 1998-11-25 | — | — | EP | disclosed |
| EP-0773934-A1 | HERBICIDAL PYRAZINE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-21 | — | — | EP | disclosed |
| EP-0489423-B1 | Bile-acid derivatives, a process for their preparation and their use as medicines | HOECHST AG (DE) | 1996-11-06 | — | — | EP | disclosed |
| EP-0697023-A1 | 3-(AMINOACYL-AMINO)-SACCHARIDES AND METHOD FOR PREPARING THEM | VEREIN DER ZUCKERINDUSTRIE (DE) | 1996-02-21 | — | — | EP | disclosed |
| EP-0576949-B1 | Optically active amino acid sulphoxide and sulphone derivatives, their preparation, their polymerisation and use as adsorbents for chromatograpic separation of racemates | BAYER AG (DE) | 1996-01-31 | — | — | EP | disclosed |
| WO-1994025474-A1 | 3-(AMINOACYL-AMINO)-SACCHARIDES AND METHOD FOR PREPARING THEM | VEREIN DER ZUCKERINDUSTRIE (DE) | 1994-11-10 | — | — | WO | disclosed |
| EP-0576949-A1 | Optically active amino acid sulphoxide and sulphone derivatives, their preparation, their polymerisation and use as adsorbents for chromatograpic separation of racemates | BAYER AG (DE) | 1994-01-05 | — | — | EP | disclosed |
| EP-0548793-A2 | Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-06-30 | — | — | EP | disclosed |
| EP-0489423-A1 | Bile-acid derivatives, a process for their preparation and their use as medicines | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-10 | — | — | EP | disclosed |
| EP-0363856-A1 | Derivative of coumarin, process for its preparation and its use | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-04-18 | — | — | EP | disclosed |